Novel Coronavirus Preparedness and Response Plan- fbg-2

Recommendations

Info

References1. WHO, Laboratory testing for 2019 novel coronavirus ( 2019-nCoV) in suspected humancases, January 2020 (https://www.who.int/docs/default-source/coronaviruse/20200117-interim-laboratory-guidance-version-final.pdf) PMHLAB-REF-07762. CDC, Interim 2019 novel coronavirus (2019-nCoV) patient under investigation (PUI) form,CDC, January 2020(https://www.cdc.gov/coronavirus/2019-nCoV/downloads/pui-form.pdf)PMHLAB-REF-07743. CDC, Influenza Specimen Collection(https://www.cdc.gov/flu/pdf/freeresources/healthcare/flu-specimen-collectionguide.pdf)PMHLAB-REF-07774. CDC, Interim Guidelines for Collecting, Handling and Testing Clinical Specimens fromPatients Under Investigation (PUIs) for 2019 Novel Coronavirus (2019-nCoV), February2020 (https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinicalspecimens.html)PMHLAB-REF-07785. CDC, Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition,December 2009(https://www.cdc.gov/labs/BMBL.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fbiosafety%2Fpublications%2Fbmbl5%2Findex.htm)PMHLAB-REF-07796. CDC Specimen Submission Form: Specimens of Human Origin(https://www.cdc.gov/laboratory/specimen-submission/form.html)PMHLAB-REF-07757. Lawrence Berkeley National Laboratory, Environmental, Safety and Health (ESH) Manual(PUB-3000), Chapter 26 Biosafety, Appendix B. Pathogen and Toxin Lists, Revised March,2019. (https://www2.lbl.gov/ehs/pub3000/CH26/CH26_Appx_B.html)PMHLAB-REF-0780Related Documents Examination by Referral Laboratories (QMM Section 5.0) External Services and Supplies (QMM Section 6.0) Advisory Service (QMM Section 7.0) Preventive Actions (QMM Section 11.0) Pre-examination Procedures (QMM Section 19.0) Examination Procedures (QMM Section 20.0) Post-examination Procedures & Reporting Results (QMM Section 22.0) Clinician User Manual (DPLM-PMHLAB-USER-SOPM-002) Safety Manual (DPLM-PMHLAB-SAFE-SOPM-004)43
Specimen Acceptability (PMHLAB-QUAL-SOP-002)Retention Time and Storage for Specimen and Records/Results (PMHLAB-QUAL-SOP-004)Suppliers and Service Providers (PMHLAB-QUAL-SOP-013)Risk Management Policy and Procedure (PMHLAB-QUAL-SOP-015)Quality Control Management Protocol (PMHLAB-QUAL-SOP-033)Non-conformances, Root Cause Analysis, Corrective Action and Preventative Action(PMHLAB-QUAL-SOP-066)Specimen Packaging and Shipping (PMHLAB-QUAL-SOP-0102)Referral Laboratory Process (PMHLAB-MG-SOP-021)Result Reporting, Critical Results and Corrected Report (PMHLAB-MG-SOP-030)DPLM Risk Rating Table (PMHLAB-QUAL-LCK-0211)Root Cause Analysis, Corrective Action and Preventative Action Flow Chart (PMHLAB-QUAL-LCK-0213)Pre-Analytical Procedures in Microbiology (PMHLAB-MICR-SOP-001)Bio-safety Procedures (PMHLAB-MICR-SOP-002)Guidelines for In Land Transportation (PMHLAB-MICR-SOP-014)Reporting of Critical and Urgent Results (PMHLAB-MICR-SOP-025)Protocol for Testing and Referring specimens to Reference Laboratories for analyses(PMHLAB-MICR-SOP-030)Quality Control in Microbiology (PMHLAB-MICR-SOP-031)Medical Microbiology Workflow (PMHLAB-MICR-SOP-035)BD Directigen RSV (PMHLAB-MICR-SOP-047)Veritor Plus System For Rapid Detection of Flu A+B (PMHLAB-MICR-SOP-085)RecordsReference Laboratory/Courier Tracking Log (PMHLAB-QUAL-LCK-031)Biological Substance, Category B - UN3373 Shipping Checklist (PMHLAB-QUAL-LCK-0159)Risk Management Plan (PMHLAB-QUAL-LCK-0188)Proforma Invoice form (for Shipping specimen) PMHLAB-QUAL-LCK-0202USA Customs Letter (Category B) PMHLAB-QUAL-LCK-0203Commercial Invoice (for Shipping specimen to CARPHA) PMHLAB-QUAL-LCK-0204Surveillance Specimen Log (PMHLAB-QUAL-LCK-0205)Referral Laboratory Results Tracking Form (PMHLAB-MG-LCK-001)Approved Reference Laboratories (PMHLAB-MG-LCK-021)Pathology and Laboratory Approved Vendor & Service Provider List PMHLAB-INV-LCK-006Reference Laboratory Tracking Chart (PMHLAB-MICR-LCK-013)Microbiology Critical/Urgent Report Communication Log (PMHLAB-MICR-LCK-017)List of Notifiable Diseases (PMHLAB-MICR-LCK-0188)Viral Respiratory Infection Work Card (PMHLAB-MICR-LCK-0189)44
Page 1 and 2: Novel Coronavirus (COVID-19)Prepare
Page 3 and 4: Table of ContentsPreface ..........
Page 5 and 6: References ........................
Page 7 and 8: International Health Regulations (I
Page 9 and 10: Risk Communication and Community En
Page 11 and 12: Protocol on Management and ControlO
Page 13 and 14: Type of Cases Definition 3Confirmed
Page 15 and 16: Management of Probable Cases in con
Page 17 and 18: Recommended safety precautions for
Page 19 and 20: Triage nurses should rapidly divert
Page 21 and 22: • Persons involved in the clean-u
Page 23 and 24: A buddy system to observe for inadv
Page 25 and 26: Equipment• Re-useable equipment s
Page 27 and 28: Addendum26
Page 29 and 30: Fever and signs/symptoms of a lower
Page 31 and 32: EMS crew should clean and disinfect
Page 33 and 34: STANDARD OPERATING PROCEDURESFORCOL
Page 35 and 36: Familiarization PageDocument contro
Page 37 and 38: See Table 1 below for other specime
Page 39 and 40: Infection Control Procedures During
Page 41 and 42: Figure 4: Triple packing method for
Page 43: Figure 6: Algorithm for Receiving,

Novel Coronavirus Preparedness and Response Plan- fbg-2

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?